LONG-TERM EVOLUTION OF TYPE III ERYTHROCYTES DURING ECULIZUMAB TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA

被引：0
|
作者：
Moncharmont, P. [1 ]
Barraco, F. [2 ]
Bernaud, J. [1 ]
Raffin, A. [1 ]
Michallet, M. [2 ]
Rigal, D. [1 ]
机构：
[1] EFS Rhone Alpes Site Lyon Gerland, Lyon, France
[2] CHLS, Dept Clin Haematol, Pierre Benite, France
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1440
引用
收藏
页码：574 / 575
页数：2
相关论文
共 50 条
  • [21] Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
    Kelly, Richard J.
    Hill, Anita
    Arnold, Louise M.
    Brooksbank, Gemma L.
    Richards, Stephen J.
    Cullen, Matthew
    Mitchell, Lindsay D.
    Cohen, Dena R.
    Gregory, Walter M.
    Hillmen, Peter
    BLOOD, 2011, 117 (25) : 6786 - 6792
  • [22] Long term stability of red cell responses in patients with paroxysmal nocturnal haemoglobinuria (PNH) on eculizumab therapy: implications for the future treatment and management of PNH
    Richards, SJ
    Cullen, MJ
    Dickinson, AJ
    Hill, A
    Buchanon, D
    Arnold, L
    Elebute, M
    Rother, RP
    Hillmen, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 16 - 16
  • [23] A case report of paroxysmal nocturnal haemoglobinuria after one year of treatment with Eculizumab
    Ucha-Samartin, M.
    Martinez-Lopez-de-Castro, N.
    Perez-Parente, D.
    Loureiro-Santamaria, C.
    Inaraja Bobo, M. T.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 290 - 291
  • [24] Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria
    Hill, A
    Hillmen, P
    Richards, SJ
    Elebute, D
    Marsh, JC
    Chan, J
    Mojcik, CF
    Rother, RP
    BLOOD, 2005, 106 (07) : 2559 - 2565
  • [25] A cascade of thromboembolic processes in a patient with paroxysmal nocturnal haemoglobinuria terminated by treatment with eculizumab
    Schutgens, Roger E. G.
    Pruissen-Peeters, Kim A. B. M.
    Muus, Petra
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (02) : 383 - 385
  • [26] Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test
    Hoechsmann, B.
    Leichtle, R.
    von Zabern, I.
    Kaiser, S.
    Flegel, W. A.
    Schrezenmeier, H.
    VOX SANGUINIS, 2012, 102 (02) : 159 - 166
  • [27] Paroxysmal nocturnal haemoglobinuria: Long-term follow-up and prognostic factors
    Socie, G
    Mary, JY
    deGramont, A
    Rio, B
    Leporrier, M
    Rose, C
    Heudier, P
    Rochant, H
    Cahn, JY
    Gluckman, E
    LANCET, 1996, 348 (9027): : 573 - 577
  • [28] Efficacy of eculizumab in paediatric patients with paroxysmal nocturnal haemoglobinuria in the International PNH Registry
    Urbano-Ispizua, A.
    Munir, T.
    Kulasekararaj, A. G.
    Bartels, M.
    Patriquin, C. J.
    Hoechsmann, B.
    Maschan, A. A.
    Wilson, A.
    Gustovic, P.
    Schrezenmeier, H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 122 - 122
  • [29] Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria
    Schubert, Joerg
    Hillmen, Peter
    Roeth, Alexander
    Young, Neal S.
    Elebute, Modupe O.
    Szer, Jeffery
    Gianfaldoni, Giacomo
    Socie, Gerard
    Browne, Paul
    Geller, Robert
    Rother, Russel P.
    Muus, Petra
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (02) : 263 - 272
  • [30] Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial
    Roeth, Alexander
    Ichikawa, Satoshi
    Ito, Yoshikazu
    Kim, Jin Seok
    Nagy, Zsolt
    Obara, Naoshi
    Panse, Jens
    Schrezenmeier, Hubert
    Sica, Simona
    Soret, Juliette
    Usuki, Kensuke
    Yoon, Sung-Soo
    Balachandran, Nadiesh
    Buri, Muriel
    Lundberg, Pontus
    Patel, Himika
    Shinomiya, Kenji
    Sostelly, Alexandre
    Nishimura, Jun-ichi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (02) : 300 - 310
12345